Jie Yuan1,2,3, Fan Zhang1, Meng You1, Qin Yang4. 1. Cancer Biology Division, Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO, 63108, USA. 2. Medical Center of Stomatology, The First Affiliated Hospital of Jinan University, 510630, Guangzhou, China. 3. School of Stomatology, Jinan University, 510630, Guangzhou, China. 4. Cancer Biology Division, Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO, 63108, USA. qyang@wustl.edu.
Retraction to: Cell Death and Disease 10.1038/s41419-018-1002-2, published online 11 September 2018The Editor-in-Chief has retracted this article. An investigation by the Office of the Vice Chancellor for Research at Washington University in St. Louis concluded that:Figure panels 1A, B, and C, labeled as cell line MDA-MB-468, appeared to be falsified and/or fabricated, and were also used in multiple NIH grant applications labeled as breast cancer cell line 4T1 or brain cancer cell line U118.Photos in figure panels 2A and 2C, labeled as breast cancer cell line MDA-MB-468, appeared to be falsified, and were also used in multiple NIH grant applications labeled as cell lines 4T1 or BT20.Figure panel 2B, labeled as breast cancer cell line MDA-MB-468, appeared to be falsified and/or fabricated, and was also labeled as brain cancer cell line GBM U118 in another publication by the same authors [1].Figure 4C, labeled as iFLs from breast cancer cell line MDA-MB-468 in the publication, appeared to be falsified and/or fabricated, and was also used in [1] labeled as iN cells.An additional concern identified as part of the investigation is the extensive overlap between this study and another article by the same authors [1].The authors have not responded to any correspondence from the editor or publisher about this retraction.